Fermata Advisors’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $390K | Buy |
|
|||||
|
2024
Q4 | $219K | Buy |
|
|||||
|
2024
Q3 | $230K | Buy |
|
|||||
|
2024
Q2 | $301K | Buy |
|
|||||
|
2024
Q1 | $370K | Buy |
|
|||||
|
2023
Q4 | $331K | Sell |
|
|||||
|
2023
Q3 | $384K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $156K | Buy |
|
|||||
|
2022
Q3 | $151K | Buy |
|
|||||
|
2022
Q2 | $212K | Buy |
|
|||||
|
2022
Q1 | $165K | Buy |
|
|||||
|
2021
Q4 | $183K | Buy |
|
|||||
|
2021
Q3 | $249K | Buy |
|
|||||
|
2021
Q2 | $206K | Buy |
|